(Press-News.org) Mass General Brigham study results signal a call to do further research into the connection between vitamin D supplementation and long COVID
In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes. Results of the study are published in The Journal of Nutrition.
“There’s been tremendous interest in whether vitamin D supplements can be of benefit in COVID, and this is one of the largest and most rigorous randomized trials on the subject,” said senior author JoAnn Manson, MD, DrPH, of the Mass General Brigham Department of Medicine. “While we didn’t find that high-dose vitamin D reduced COVID severity or hospitalizations, we observed a promising signal for long COVID that merits additional research.”
Vitamin D has been hypothesized to boost immune health, but clinical evidence in the context of COVID-19 has been mixed. The Vitamin D for COVID-19 (VIVID) Trial aimed to provide clarity by rigorously evaluating high-dose vitamin D3 supplementation among newly diagnosed COVID-19 patients and their household contacts. Across the United States and Mongolia, 1,747 adults who had recently tested positive for COVID-19 and 277 household contacts were randomized to receive either daily vitamin D3 (9,600 IU/day for two days followed by 3,200 IU/day) or daily placebo for four weeks. The U.S. trial was conducted from December 2020 to September 2022 while the Mongolia trial ran from September 2021 to April 2022. The median time between the participants’ positive COVID-19 tests and the initiation of vitamin D supplementation or placebo was three days.
Alongside Manson, lead authors Davaasambuu Ganmaa, Kaitlyn Cook and team used stratified randomization and statistical weighting to ensure factors that can affect COVID-19 outcomes (including age, sex, body mass index, race/ethnicity and COVID-19 vaccination status) were balanced between the two groups.
The rate of healthcare utilization (including hospitalizations, in-person or virtual clinic visits, and emergency visits) or death did not differ between the vitamin D and placebo groups over a four-week period. Similarly, no significant differences were found in symptom severity. Taking high-dose vitamin D also didn’t reduce the rate at which household contacts contracted COVID-19.
However, an analysis of the participants who adhered to the vitamin D regimen demonstrated a signal that they were less likely to experience long COVID symptoms at eight weeks than those who took placebo pills. In the vitamin D group, 21% reported at least one persistent symptom, compared to 25% in the placebo group, a difference of borderline statistical significance.
“Long COVID, which can include symptoms of fatigue, shortness of breath, brain fog, other cognitive challenges and more, continues to significantly impact people’s lives,” said Manson. “We hope to conduct further research in larger populations on whether long-term vitamin D supplementation reduces the risks and severity of long COVID.”
Authorship: In addition to Manson and Ganmaa, Mass General Brigham authors include Allison Clar, Michael Rueschman, Aditi Hazra, Howard D. Sesso, Valerie E. Stone, Patricia Copeland and Georgina Friedenberg. Additional authors include Cook, Polyna Khudyakov, Dorjbal Enkhjargal, Tsolmon Bilegtsaikhan, Kenneth H. Mayer, Raji Balasubramanian, Douglas C. Smith, Quanhong Lei, Todd Lee, Emily G. McDonald, Tserenkhuu Enkhtsetseg, Erdenebaatar Sumiya, Yansanjav Narankhuu, Myagmarsuren Erdenetuya, Dalkh Tserendagva, Rikard Landberg, Niclas Roxhed and Susanne Rautiainen.
Disclosures: Roxhed is a founder and shareholder of Capitainer AB, a company commercializing the blood collection devices used in this study. All other authors declare no conflicts of interests.
Funding: The study received anonymous foundation support and philanthropic support from Jon Sabes of Minneapolis, Minn. The authors also acknowledge support from the Tishcon Corporation, which donated the vitamin D and placebo study capsules; Takeda; and Capitainer cards. The authors have not declared a specific grant for this research from any funding agency in the public, commercial or nonprofit sectors.
Paper cited: Ganmaa, D., et al. “A Randomized Trial of Vitamin D Supplementation and COVID-19 Clinical Outcomes and Long COVID: The VIVID Trial.” The Journal of Nutrition. DOI: 10.1016/j.tjnut.2026.101398
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
A new study led by UCLA researchers suggests that a personalized counseling program can significantly help women who have survived cervical precancer or cervical cancer to quit smoking — and does so at a cost that researchers say represents good value for healthcare systems.
The findings, published in JAMA Network Open, show that the specialized program, called Motivation and Problem-Solving (MAPS), which combines standard nicotine replacement therapy with up to six individualized counseling sessions over a year, helped twice as many women quit smoking compared to women who had standard smoking cessation support.
“Smoking is a major risk factor for cancer recurrence and ...
About The Study: In this cohort study, adverse childhood experience (ACE) exposure was associated with an increased risk of treatment-resistant depression even after accounting for unmeasured familial confounding. The findings highlight the importance of preventing ACEs and incorporating ACE history into clinical assessment to identify individuals with major depressive disorder who may be at elevated risk for treatment resistance.
Corresponding Author: To contact the corresponding author, Ying Xiong, PhD, MMedSc, email ying.xiong@ki.se.
To access the embargoed study: Visit our For The Media website at this ...
About The Study: This study estimated the increase in 12-month psilocybin use in Oregon and Colorado associated with decriminalization.
Corresponding Author: To contact the corresponding author, Joshua C. Black, PhD, email joshua.black@rmpds.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2026.1952)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, ...
A new, national analysis published in the Aesthetic Surgery Journal suggests the future growth of aesthetic surgery may lie far from traditional luxury markets. UC Davis Health researchers found that Southern, Midwestern and rural regions of the United States are growing as high-demand areas, despite limited access to board-certified plastic surgeons.
The study, conducted by researchers at UC Davis Medical Center, analyzed Google search behavior alongside workforce data across 210 U.S. Designated Market Areas. Researchers found that consumer demand is rising nationwide but remains unevenly matched with surgeon distribution. This imbalance has revealed multiple “plastic surgery deserts” ...
A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial personalized feedback.
Rebecca Krukowski, PhD, and her colleagues are aiming to support people who track or “self-monitor” their diet, exercise and weight in weight-management programs. The researchers will create a semi-automated feedback system to find the “sweet spot” of combining human expertise and support with automated feedback to help participants stay on ...
(WASHINGTON — Mar. 12, 2026) — Hematology-oncology trained physicians who treat sickle cell disease reported higher rates of burnout (60%) than their counterparts who do not provide sickle cell care (43%) despite no differences in grit and resilience between the two groups. The data were published in the American Society of Hematology’s journal, Blood Advances.
“This is the first and only data on burnout, grit, ...
The Amazon rainforest is famous for storing massive amounts of carbon in its trees and soils, helping regulate the global climate. Yet a paper published today in New Phytologist shows that one of South America’s largest carbon-storing ecosystems exists in an often-overlooked grassy savanna: the Cerrado in Brazil.
The study was led by Larissa Verona, a technician working with senior scientist Amy Zanne at Cary Institute of Ecosystem Studies and a former graduate student at Universidade Estadual de Campinas in Brazil, where she carried out the work. The study is the first in-depth assessment of carbon stocks in the Cerrado’s groundwater-fed wetlands, known ...
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms, characterized by muscle wasting, paralysis, dementia, and other serious impairments. There are currently no effective treatments. Many patients have a common hallmark: A protein called TDP-43 clumps together in the neurons of the brain to form tiny lumps. Researchers at DZNE and Ulm University Hospital, together with international experts, have now discovered ...
WASHINGTON—A mouse study found that a father’s nicotine exposure can affect the offspring’s ability to process sugar and may contribute to diabetes risk, according to new research published in the Journal of the Endocrine Society.
An estimated 40.1 million people in the United States have diabetes, according to the U.S. Centers for Disease Control and Prevention. Having diabetes puts people at risk of developing other conditions like heart disease, kidney disease and nerve damage. Since diabetes affects more than 12 percent of Americans and is a chronic disease, the costs of treatment are high.
Tobacco ...
PLYMOUTH MEETING, PA [March 12, 2026] — New research in the March 2026 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests that exercise may help people with cancer stay mentally sharp and better able to handle daily tasks, work, and social activities through chemotherapy treatment delivered on an every two-week cycle. This first-of-its-kind, nationwide, multicenter, phase III trial randomized patients to receive an exercise prescription, Exercise for Cancer Patients (EXCAP©®), which included individually-tailored walking and simple resistance band exercises, along with their usual chemotherapy treatment. By ...
